Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA approves supplemental BLA for Gazyva

Dec. 30, 2014

Kite Pharma submits IND application for phase I/II trial of KTE-C19

Dec. 29, 2014

First U.S. approval granted for nivolumab injection for metastatic melanoma

Dec. 23, 2014

NETRIS Pharma creates first humanized monoclonal antibody against netrin-1

Dec. 23, 2014

Inovio Pharmaceuticals begins DNA immunotherapy trial for breast, lung and pancreatic cancer

Dec. 23, 2014

Kyowa Hakko Kirin receives additional indication approval for Poteligeo in Japan

Dec. 22, 2014

Preliminary phase I/IIa data for an anticancer vaccine against multiple myeloma

Dec. 18, 2014

Preclinical data for RG-7888 support phase I investigation

Dec. 18, 2014

Prima BioMed initiates pilot trial of CVac in pancreatic cancer

Dec. 18, 2014

Activity of fully human bispecific antibody against B-cell lymphoma described

Dec. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...